Keytruda Expands Cervical Cancer Position With ESMO Data

 
• By Alaric DeArment
  
3d illustration of T cells attacking a cancer cell
Merck presented data at ESMO on Keytruda in first-line cervical cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer